Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Gastrointestinal side effects, difficulty accessing therapeutic doses and poor patient compliance have been identified as barriers to effective treatment with these substances. The rivastigmine transder...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:CNS Neurosci Ther
Hoofdauteurs: Emre, Murat, Bernabei, Roberto, Blesa, Rafael, Bullock, Roger, Cunha, Luis, Daniëls, Hugo, Dziadulewicz, Edward, Förstl, Hans, Frölich, Lutz, Gabryelewicz, Tomasz, Levin, Oleg, Lindesay, James, Martínez‐Lage, Pablo, Monsch, Andreas, Tsolaki, Magda, Van Laar, Teus
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Blackwell Publishing Ltd 2010
Onderwerpen:
Alzheimer's Disease
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493902/
https://ncbi.nlm.nih.gov/pubmed/20370805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00141.x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items